Guaraná Mariana, Soares Andréa, Daumas Adelmo, Biasoli Irene, Solza Cristiana
Faculdade de Medicina, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Faculdade de Ciências Médicas, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):321-327. doi: 10.1016/j.htct.2020.10.966. Epub 2021 Jan 3.
Constitutional symptoms and thrombohemorrhagic events are common in patients with myeloproliferative neoplasms (MPNs). Hence, the treatment's primary goal is to control symptoms and improve the quality of life (QoL). In order to assess response to therapy, symptom burden, and QoL among patients with MPN, the "Myeloproliferative Neoplasm Symptom Assessment Form - Total Symptom Score (MPN-SAF TSS)" questionnaire was developed in the USA in 2012. Herein, we translated and validated the MPN-SAF TSS questionnaire to Brazilian Portuguese.
The ten-item questionnaire was translated from the English language and its psychometric properties (reliability, convergent and construct validities) were evaluated in 101 MPN patients.
There were 41 patients with essential thrombocythemia, 39 with myelofibrosis and 21 with polycythemia vera. The median age of all patients at diagnosis was 68 years and 59% were female. The Cronbach's alpha coefficient for the overall questionnaire was 0.78, ranging from 0.73 to 0.79, if each item was deleted. Validity analyses showed that the strongest item-item correlation were between early satiety and abdominal discomfort. Strong correlations were also found between physician and patient perceptions of itching (r=0.81) and fatigue (r=0.70). The Pearson coefficient correlation between the MPN-SAF TSS global score and the EORTC QLQ-C30 functional scales ranged from 0.51 to 0.64. The exploratory factor analysis showed that seven of the ten symptoms loaded into one single factor.
The Brazilian Portuguese version of the MPN-SAF-TSS showed good psychometric properties and can be an available tool to assess symptom burden in this group of patients.
骨髓增殖性肿瘤(MPN)患者常出现全身症状及血栓出血事件。因此,治疗的主要目标是控制症状并改善生活质量(QoL)。为评估MPN患者的治疗反应、症状负担及生活质量,2012年美国开发了“骨髓增殖性肿瘤症状评估表 - 总症状评分(MPN-SAF TSS)”问卷。在此,我们将MPN-SAF TSS问卷翻译成巴西葡萄牙语并进行了验证。
这份十项问卷从英语翻译而来,并在101例MPN患者中评估了其心理测量特性(信度、收敛效度和结构效度)。
41例原发性血小板增多症患者,39例骨髓纤维化患者,21例真性红细胞增多症患者。所有患者诊断时的中位年龄为68岁,59%为女性。整个问卷的Cronbach's alpha系数为0.78,若删除每个项目,该系数范围为0.73至0.79。效度分析表明,最强的项目间相关性存在于早饱与腹部不适之间。在医生和患者对瘙痒(r = 0.81)和疲劳(r = 0.70)的认知之间也发现了强相关性。MPN-SAF TSS全球评分与欧洲癌症研究与治疗组织QLQ-C30功能量表之间的Pearson系数相关性范围为0.51至0.64。探索性因子分析表明,十个症状中的七个加载到一个单一因子中。
巴西葡萄牙语版的MPN-SAF-TSS显示出良好的心理测量特性,可作为评估该组患者症状负担的可用工具。